Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of zuclopenthixol on aggressive behaviour in children and adolescents with intellectual disability or learning disability
2008-000584-42Phase 4Completed
- Sponsor
- Universität Rostock
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of zuclopenthixole in intermittent explosive disorder (IED), intellectual disability (ID) and learning disorder, sponsored by Universität Rostock. Primary endpoint: Aggressive behaviour measured by MOAS. Started Apr 2008; status: completed.
02
Drugs
zuclopenthixole
03
Conditions
intermittent explosive disorder (IED)intellectual disability (ID)learning disorder
Beyond the preview
Go deeper on 2008-000584-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000584-42.